July 10, 2017 M&A, Partnerships

Roka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE Bioscience

Roka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE Bioscience WARREN, N.J., July 10, 2017 /PRNewswire/ — Roka Bioscience, Inc. (“Roka”) (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that it has entered into a two year nonexclusive supply agreement with PURE Bioscience... Read more

July 7, 2017 M&A, Partnerships Microscopy Molecular Spectroscopy PR/Corporate

Agilent Technologies Acquires Raman Spectroscopy Innovator, Cobalt Light Systems

Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 7, 2017– Agilent Technologies Inc. (NYSE:A) today announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems (“Cobalt”), a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied... Read more

July 7, 2017 M&A, Partnerships Microscopy Molecular Spectroscopy PR/Corporate

Agilent Technologies Acquires Raman Spectroscopy Innovator, Cobalt Light Systems

Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 7, 2017– Agilent Technologies Inc. (NYSE:A) today announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems (“Cobalt”), a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied... Read more

July 7, 2017 Lab Top-10 M&A, Partnerships Microscopy Molecular Spectroscopy

Agilent Technologies Acquires Raman Spectroscopy Innovator, Cobalt Light Systems

Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers SANTA CLARA, Calif., July 7, 2017 Agilent Technologies Inc. (NYSE: A) today announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems (“Cobalt”), a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry,... Read more

July 5, 2017 M&A, Partnerships

Brooks Automation Announces the Acquisition of Pacific Bio-Material Management, Inc.

CHELMSFORD, Mass., July 05, 2017 (GLOBE NEWSWIRE) — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that it has acquired Pacific Bio-Material Management, Inc. (PBMMI), a premier service provider of storage and cold-chain logistics for biological sample materials. Brooks paid $33 million in cash for PBMMI, which is headquartered in Torrance, California. The acquisition includes the operations... Read more

July 4, 2017 M&A, Partnerships

Hitachi High-Technologies’ Stock Purchase (Subsidiary Acquisition) and Business Acquisition of Part of the Oxford Instruments plc Group and Overview of the New Company

(PDF format, 164kBytes) July 4, 2017 Tokyo, Japan, July 4, 2017 – Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced today that, as noted in the April 26, 2017 news release titled “Hitachi High-Technologies Enters Into an Agreement on the Stock Purchase (Subsidiary Acquisition) and Business Acquisition of Part of the Industrial Precision Instruments Business... Read more

July 4, 2017 M&A, Partnerships

Completion of Sale of Industrial Analysis business to Hitachi High-Technologies

03 July 2017 Completion of Sale of Industrial Analysis business to Hitachi High-Technologies Further to the announcement made on 26 April 2017, Oxford Instruments plc, a leading provider of high technology solutions, information and services for industry and research, today announces that it has completed the sale of its Industrial Analysis business to Hitachi High-Technologies... Read more

July 4, 2017 M&A, Partnerships

ImmunoPrecise To Acquire U-Protein and Announces $4,000,000 Financing

Victoria, British Columbia, Canada, July 4, 2017 – IMMUNOPRECISE ANTIBODIES (the “Company”) (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has signed a binding letter of intent with U-Protein Express BV (“U-Protein“) whereby the Company has agreed to acquire all of the issued and outstanding shares of U-Protein (the “Transaction”).  This represents a key step in the... Read more

June 30, 2017 M&A, Partnerships

Precipio Diagnostics and Transgenomic Complete Merger

Company Renamed Precipio, Inc.–To Commence Trading On NASDAQ Under The New Ticker “PRPO” NEW HAVEN, Conn. and OMAHA, Neb., (June 30, 2017) – Precipio Diagnostics, LLC and Transgenomic Inc. (OTCQB: TBIOD) today announced the closing of their previously announced merger. In connection with the transaction, Transgenomic has changed its name to Precipio, Inc. Precipio’s common stock... Read more